Printer Friendly

Blood Group Typing Market to Reach USD 3bn by 2021, Research and Markets Forecasts.

M2 PHARMA-May 8, 2017-Blood Group Typing Market to Reach USD 3bn by 2021, Research and Markets Forecasts

(C)2017 M2 COMMUNICATIONS

- The blood group typing market is projected to reach USD 3.12bn by 2021 from USD 1.95bn in 2016, at a CAGR of 9.8%, according to a new report from Dublin-based Research and Markets.

Growth in the blood group typing market is primarily attributed to the increasing demand for blood and blood products, growing number of road accidents and trauma cases that necessitate blood transfusion, need for blood grouping during prenatal testing, and increasing usage of blood group typing in forensic sciences.

Stringent regulatory standards for blood transfusion are also expected to fuel the growth of the blood group typing market during the forecast period.

Based on product and service, the market is segmented into consumables, instruments, and services. The consumables segment is further categorised into antisera reagents, anti-human globulin reagents, red blood cells reagents, and blood bank saline.

The consumables segment is expected to grow at the highest CAGR during the forecast period. The increase in blood donation rates and major surgical procedures (including organ transplant procedures) are the key factors driving the growth of this segment.

Based on test type, the market is segmented into antibody screening, HLA typing, cross-matching tests, ABO blood tests, and antigen typing.

The antibody screening segment is expected to grow at the highest CAGR during the forecast period. The growth of this market segment is primarily driven by the increasing prevalence of chronic disorders and growing demand for the early diagnosis of diseases.

Key players in this market include Axo Science, Agena Bioscience, Inc., Bag Health Care GmbH, Beckman Coulter (A Subsidiary of Danaher), Bio-Rad Laboratories, Inc., Day Medical SA, Grifols International, S.A., Immucor, Inc., Merck KGaA, Novacyt Group, Ortho Clinical Diagnostics, Inc., Quotient, Ltd. and Rapid Labs.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:May 8, 2017
Words:320
Previous Article:Cancer Diagnostics Market to Reach USD 232.7bn by 2025, Research and Markets Forecasts.
Next Article:Zeldis Named Chairman of the MetaStat Board of Directors.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters